1NascaCell IP GmbH, München, Germany.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Synthetic nucleic acid aptamers offer high specificity and affinity for protein targets, significantly advancing drug development. This technology enables rapid identification of aptamers for high-throughput analysis and validation of drug targets.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: